NPC

Clinical trials for NPC explained in plain language.

Never miss a new study

Get alerted when new NPC trials appear

Sign up with your email to follow new studies for NPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug duo aims to shrink throat cancer before standard therapy

Disease control Not yet recruiting

This study tests whether giving two drugs—pembrolizumab and MRG-003—before standard chemoradiation can improve outcomes for people with advanced nasopharyngeal cancer linked to the Epstein-Barr virus. About 35 adults with stage III-IVa disease will receive the combination, then s…

Matched conditions: NPC

Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated May 19, 2026 11:47 UTC

NPC

Get alerted when new NPC trials appear

New drug duo aims to shrink throat cancer before standard therapy